Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. - Wikidata - wikimedia - TriplyDB

Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.

Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.

http://www.wikidata.org/entity/Q37020820

about

Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis.Adenylyl cyclase signaling in the developing chick heart: the deranging effect of antiarrhythmic drugs Hypertension in women of reproductive age in the United States: NHANES 1999-2008.Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population.Drugs in pregnancy: Implications for a cardiologist.Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study.Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore-Washington Infant Study Is maternal parity an independent risk factor for birth defects?Trends in pre-pregnancy diabetes among deliveries in 19 U.S. states, 2000-2010.Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis.Are hypertensive disorders in pregnancy associated with congenital malformations in offspring? Evidence from the WHO Multicountry cross sectional survey on maternal and newborn health.Factors associated with major structural birth defects among newborns delivered at Muhimbili National Hospital and Municipal Hospitals in Dar Es Salaam, Tanzania 2011 - 2012.Use of antiepileptic medications in pregnancy in relation to risks of birth defects Reversible Fetal Renal Impairment following Angiotensin Receptor Blocking Treatment during Third Trimester of Pregnancy: Case Report and Review of the Literature.Association of maternal chronic disease with risk of congenital heart disease in offspring Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversies.The pathogenesis of atrial and atrioventricular septal defects with special emphasis on the role of the dorsal mesenchymal protrusion.Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.Nongenetic risk factors and congenital heart defects.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014.In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.Atrial fibrillation in pregnancy: a growing challenge.The changing epidemiology of Ebstein's anomaly and its relationship with maternal mental health conditions: a European registry-based study.Renin-Angiotensin System Blocker Fetopathy.Antihypertensive drugs and the risk of congenital anomalies.Fetal risk from angiotensin converting enzyme inhibitors in the first trimester.Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study.The effects of poor maternal nutrition during gestation on postnatal growth and development of lambs.Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.Angiotensin receptor blockade in diabetic women of childbearing potential: an acceptable risk?Analysis of selected maternal exposures and non-syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005.Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study Maternal hypertension and risk for hypospadias in offspring

P2860

Q26991704-0E7344C2-9BB3-40D7-BDC2-892DA5B19B1B Q33863487-6ADF8B8E-8C4D-47E7-B508-B5E9ABB21CB2 Q33876726-341B5316-F1C9-4F8D-A4C0-669A6E92FFB4 Q34257254-5BDA4D4B-CCF1-400F-BFEA-187C767AB220 Q34298992-3EC31E9B-BF0B-499A-9195-F00FD9A5C06E Q34467069-3632017D-8249-4F4D-A4EF-1B9BEB928C2C Q35137516-F084E82B-A463-4A42-9555-563F71E0687B Q35384541-4063B521-4215-4D1B-B724-ED34B96DEBA4 Q35525008-2C080C68-1DC8-4AE3-A1A8-67800A6661F6 Q35764608-69D19E50-CFF4-4ABC-98F8-A6725F13AF64 Q35800081-A1DF5ABE-4FE4-47AA-B6EC-F26E069E523B Q36069029-E143D6B5-E33B-4387-A01E-57A579AA3C29 Q36090080-41FD43E9-DE8E-4215-8966-EFA8F6FA68B9 Q36185730-BF21CA5E-C307-45BA-A2E1-CB066ADF8D77 Q36751405-321FB52F-19A0-4375-8C2C-E4DB72E0BB9C Q37273818-26F7C468-3DC6-4B29-A03A-A3386D52C051 Q37470027-1EE0CA4B-B1FE-4230-8C12-8C7402E8430F Q37861890-7BDEF2D4-98BA-4011-86CE-99722943010B Q38019645-ACB61495-E6F8-48C9-B25C-17B0E53B542E Q38027126-A19469D6-37F4-43CA-8DD9-47B97F268654 Q38130429-2AF0D2CF-6EFF-4246-84D0-F40C0FFF7138 Q38328807-233C1A8A-B5CB-4952-93D4-444327E8B22A Q38594110-B87BE497-779F-448B-A92E-C5398E0652EC Q38702465-D5434109-14CE-4665-912B-3D1FCB7C40F4 Q38789706-E2487DA5-1442-4E83-8597-1BA8FAD75BF2 Q39442897-BF9003BE-ED27-4870-946C-D39C052E4BC8 Q43195095-D0CF5A46-6A4C-4AE6-AF47-06EE54749B03 Q46254956-DE8C74CA-A9DE-4B01-A544-14C1DEAAC5E0 Q47133526-2DE2DB65-4041-4222-98BC-76B75B8E258B Q47325847-975BF7E1-170E-4C06-A085-18F2CF993EC8 Q47436830-71BBC0B9-A758-4701-964D-A93F93A33DAA Q47839950-2B572D72-ADBE-44C0-B515-AF69A6920183 Q53107393-123B1B83-119E-4487-9C92-8330069BB422 Q54254904-39537312-10B0-4C66-AD1D-B85A17B1547F Q55686874-47ABE9EC-3AEA-467A-8E49-62CA12AC4AC0 Q58934061-78ACE13F-23A5-4CE4-9F62-2EDFDCA05BF3 Q59192482-187DC592-9632-4A09-8E51-4A0C7E18E008

P2860

Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.

http://www.wikidata.org/entity/Q37020820

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antihypertensive medication us ...... cardiovascular malformations.

@en

Antihypertensive medication us ...... cardiovascular malformations.

@nl

type

label

Antihypertensive medication us ...... cardiovascular malformations.

@en

Antihypertensive medication us ...... cardiovascular malformations.

@nl

prefLabel

Antihypertensive medication us ...... cardiovascular malformations.

@en

Antihypertensive medication us ...... cardiovascular malformations.

@nl

P1433

Q37020820-507D064F-85D5-4C84-9540-61178D8EFEFC

P1476

Q37020820-BDD759DA-1F03-4288-A906-9640C38554DF

P2093

Q37020820-08CF97DF-34C8-40F6-B4DF-F09FD0E66C74

Q37020820-0F0C438E-A559-4C6E-8870-385134DE89E5

Q37020820-596523B7-037A-42FE-AC5C-AFCE49F6BAC2

Q37020820-6B5B7D53-9A51-4547-8C45-7952D8FA4D28

Q37020820-7226B1E0-076B-449A-9AE9-E488C1657E58

Q37020820-908345E3-464A-4177-91AA-7CE54094E87A

Q37020820-93F38B98-9E02-441B-8A50-F2093F66A9E5

Q37020820-DB56800F-6035-43F4-940D-079462DF83DC

P2860

Q37020820-09AF152F-410A-4683-ADD4-A236C1094AA7

Q37020820-0DCDFBEC-F4A7-496F-8A99-B99C43F63D7A

Q37020820-1247AAD5-517B-4FF8-BD9E-FADA25609643

Q37020820-16DADDCF-128A-4735-AC49-8FB356C49B7A

Q37020820-172AC0D6-F8A6-4187-B313-3DEA4E78ACBB

Q37020820-181C3E81-AE8F-4A3C-8830-721BA1BAB53A

Q37020820-1E622621-1856-4B95-9694-58077CC1B8D8

Q37020820-1FD5CD39-7973-43FF-83F7-F10BCE3A7C07

Q37020820-34E5E855-0526-430A-9745-C2298D72CC37

Q37020820-3781539B-0B04-4E30-A298-48D8BEE98CC1

P304

Q37020820-E2F3AD2C-CAC0-4DD2-A0FB-3FE3F8CDCDFF

P31

Q37020820-3B094B09-5990-4255-B887-C34A812ED87C

P356

Q37020820-CA6D15AD-A57F-49FF-85D6-62E163586873

P407

Q37020820-3AF6069E-63A5-4D2A-9534-202B8EAA6B76

P433

Q37020820-4D61A537-6D2E-4106-BAD5-0781999E157E

P478

Q37020820-94A9EF77-E6FF-4AA0-838C-F510B7818A3A

P50

Q37020820-00890753-29A7-4656-9443-2ADEF08B1EB0

Q37020820-4132547B-272D-4231-ADD7-97FD66E504CB

Q37020820-9B939E86-162E-4FD5-B09D-380D5A395C2E

Q37020820-EADDB0DC-C6E0-41AE-87FB-1CBEEB8DE800

P577

Q37020820-012364BF-0BA7-4AAA-982D-99C811B35335

P698

Q37020820-43C9C512-30C8-46A4-977A-77562D09F908

P921

Q37020820-B27434F6-F42D-4AD4-887A-DD673B4961A2

P932

Q37020820-398FFB12-CA70-4026-90F5-1326106BE0BC

P356

HYPERTENSIONAHA.109.129098

P1433

P1476

Antihypertensive medication us ...... cardiovascular malformations.

@en

P2093

Adolfo Correa

http://www.w3.org/2001/XMLSchema#string

Alissa R Caton

http://www.w3.org/2001/XMLSchema#string

Angela E Lin

http://www.w3.org/2001/XMLSchema#string

Charlotte M Druschel

http://www.w3.org/2001/XMLSchema#string

Erin M Bell

http://www.w3.org/2001/XMLSchema#string

Louise-Anne McNutt

http://www.w3.org/2001/XMLSchema#string

Marilyn L Browne

http://www.w3.org/2001/XMLSchema#string

Richard S Olney

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Treating hypertension in women of child-bearing age and during pregnancy.

Difficulties in the study of adverse fetal and neonatal effects of drug therapy during pregnancy.

Major congenital malformations after first-trimester exposure to ACE inhibitors.

Atenolol in essential hypertension during pregnancy

Pharmacological treatment of hypertension in pregnancy.

Influence of twin-twin transfusion syndrome on fetal cardiovascular structure and function: prospective case-control study of 136 monochorionic twin pregnancies.

The National Birth Defects Prevention Study.

Angiotensin II receptor antagonist treatment during pregnancy.

Methodological issues in the epidemiological study of the teratogenicity of drugs.

P304

63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.109.129098

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Martha M Werler

Allen A Mitchell

National Birth Defects Prevention Study

P577

2009-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19433779

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

4913772

http://www.w3.org/2001/XMLSchema#string